IP Library › Granted Patent US 12,371,694
Granted Patent B2
US 12,371,694 · App. 17/289,767 · Granted Jul 29, 2025

Compositions and methods for the synthesis and identification of covalent aptamers

Inventor: Iain Seido MacPherson (Honolulu, HI)
Assignee: University of Hawaii
C12N15/115C07H19/10C07H21/04C12N15/1048C12N2310/16C12N2310/314C12N2310/3513
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,371,694
App. No.
17/289,767
Granted
Jul 29, 2025
Kind
B2
Abstract

Compositions and methods for preparing and identifying aptamers and aptamer-protein conjugates are provided. The use of a nucleotide analog functionalized with an amine-reactive cross-linker facilitates covalent cross-linking of the aptamer to a protein, in particular site-specific cross-linking to the Fc domain of an antibody.

Claims (14)

1. A method for producing one or more aptamers that bind to a target protein comprising

(a) contacting a target protein with an aptamer library comprising a plurality of aptamers each having at least one nucleotide analog functionalized with an amine-reactive cross-linker;

(b) selecting from the aptamer library one or more aptamers that covalently bind, and exhibit specific binding affinity for, the target protein; and

(c) introducing a triazole-modified nucleotide into the sequence of the one or more aptamers that covalently bind, and exhibit specific binding affinity for, the target protein, wherein the triazole-modified nucleotide is introduced into the one or more aptamers by:

(i) incorporating a phosphoramidite comprising the structure of Formula I:

wherein R 1 is H, O-methyl, dimethyl, fluoro, amino, C-allyl, arabinofluoro, methylene, difluoromethylene or a protecting group; and R 2 is a protecting group,

(ii) deprotecting the aptamers, and

(iii) activating the deprotected aptamers to form an amine-reactive cross-linker.

2. A phosphoramidite comprising the structure of Formula I:

wherein R 1 is H, O-methyl, dimethyl, fluoro, amino, C-allyl, arabinofluoro, methylene, difluoromethylene or a protecting group; and R 2 is a protecting group.

3. A kit comprising the phosphoramidite of claim 2 .

4. The method of claim 1 , wherein each aptamer of the plurality of aptamers is bound to an unmodified double-stranded DNA copy of the aptamer.

5. The method of claim 1 , wherein the at least one nucleotide analog is 5-ethynyldeoxyuridine, 5-ethynyluridine, or 2′-modified 5-ethynyluridine.

6. The method of claim 1 , wherein the amine-reactive cross-linker is an N-hydroxysuccinimide ester or imidoester.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 29, 2021
From: MACPHERSON, IAIN SEIDO
To: UNIVERSITY OF HAWAII
Reel/Frame 056079/0854 →
Continuity (2)
Provisional Application 62767363 · Nov 14, 2018
Related Publication 20210395742A1 · Dec 23, 2021
References Cited (19)
US 20140100120A1 · Gorenstein · 2014 [cited by examiner]
WO WO2014047357A1 · 2014 [cited by examiner]
WO WO2014047375A1 · 2014 [cited by examiner]
WO 2016005474A1 · 2016 [cited by applicant]
WO 2017053905A1 · 2017 [cited by applicant]
WO 2018152470A1 · 2018 [cited by applicant]
Miyakawa et al. “Structural and molecular basis for hyperspecificity of RNA aptamer to human immunoglobulin G” (RNA (2008) 14(6):1154-63). (Year: 2008). [cited by examiner]
Diafa, S. et al. (2015) “Generation of aptamers with an expanded chemical repertoire,” Molecules 20(9):16643-16671. [cited by applicant]
He, W. et al. (2012) “X-Aptamers: A bead-based selection method for random incorporation of drug-like moieties onto next-generation aptamers for enhanced binding,” Biochemistry 51(42):8321-8323. [cited by applicant]
International Search Report and Written Opinion in PCT/US2019/061096 dated Apr. 7, 2020. [cited by applicant]
MacPherson, I.S. et al. (2018) “Chemically ‘barbed’ aptamers selected from a base-modified RNA library,” Aptamers 2:74-81. [cited by applicant]
Pfeiffer, F. et al. (2018) “Identification and Characterization of nucleobase-modified aptamers by click-SELEX,” Nature Protocols 13(5):1153-1180. [cited by applicant]
Smith, D. et al. (2003) “Sensitivity and specificity of photoaptamer probes,” Mol. Cell. Proteom. 2:11-18. [cited by applicant]
Temme, J.S. et al. (2013) “Directed Evolution of 2G12-Targeted Nonamannose Glycoclusters by SELMA,” Chemistry 19:17291-95. [cited by applicant]
Temme, J.S. et al. (2014) “High Temperature SELMA: Evolution of DNA-Supported Oligomannose Clusters Which Are Tightly Recognized by HIV bnAb 2G12,” J. Am. Chem. Soc. 136:1726-29. [cited by applicant]
Temme, J.S. “SELMA: Selection with Modified Aptamers,” Curr. Protoc. Chem. Biol. 7:73-92. [cited by applicant]
Van Buggenum, J.A.G.L. et al. (2016) “A covalent and cleavable antibody-DNA conjugation strategy for sensitive protein detection via immuno-PCR,” Scientific Reports 6:22675. [cited by applicant]
International Preliminary Report on Patentability in PCT/US2019/061096 dated May 27, 2021. [cited by applicant]
Miyakawa, S., et al. (2008) “Structural and molecular basis for hyperspecificity of RNA aptamer to human Immunoglobulin G,” RNA 14:1154-1163. [cited by applicant]